Progressive Care, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 06:23 am
Share
Progressive Care, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 11.56 million compared to USD 9.97 million a year ago. Net loss was USD 4.64 million compared to USD 0.880722 million a year ago. Basic loss per share from continuing operations was USD 1.05 compared to USD 0.32 a year ago. Diluted loss per share from continuing operations was USD 1.05 compared to USD 0.32 a year ago.
For the six months, sales was USD 22.95 million compared to USD 20.02 million a year ago. Net loss was USD 4.77 million compared to USD 2.24 million a year ago. Basic loss per share from continuing operations was USD 1.22 compared to USD 0.82 a year ago. Diluted loss per share from continuing operations was USD 1.22 compared to USD 0.82 a year ago.
Progressive Care, Inc. is a personalized healthcare services and technology provider. The Company operates through two segments: Pharmacy Operations and Third-Party Administration. The Pharmacy Operations segment provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, COVID-19 related diagnostics and vaccinations, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, and contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program. The Third-Party Administration segment provides data management and reporting services to support health care organizations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian and Russian. Through its wholly owned subsidiary, ClearMetrX, it offers data management and reporting services to support health care organizations.